What's new in ECMO for COVID-19?
作者信息
MacLaren Graeme, Combes Alain, Brodie Daniel
机构信息
Cardiothoracic Intensive Care Unit, National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.
Institute of Cardiometabolism and Nutrition, Sorbonne University, INSERM Unite Mixte de Recherche (UMRS) 1166, Paris, France.
出版信息
Intensive Care Med. 2021 Jan;47(1):107-109. doi: 10.1007/s00134-020-06284-z. Epub 2020 Nov 12.
Abstract
摘要
相似文献
1
What's new in ECMO for COVID-19?用于治疗新冠肺炎的体外膜肺氧合（ECMO）有哪些新进展？
Intensive Care Med. 2021 Jan;47(1):107-109. doi: 10.1007/s00134-020-06284-z. Epub 2020 Nov 12.
2
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.COVID-19 患者的体外膜肺氧合治疗：国际体外生命支持组织注册研究的结果演变。
Lancet. 2021 Oct 2;398(10307):1230-1238. doi: 10.1016/S0140-6736(21)01960-7. Epub 2021 Sep 29.
3
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.COVID-19 患者在体外膜肺氧合（ECMO）治疗期间的管理：注意获得性血管性血友病。
J Atheroscler Thromb. 2021 Apr 1;28(4):396-401. doi: 10.5551/jat.58362. Epub 2020 Oct 28.
4
Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的重症新型冠状病毒肺炎急性呼吸窘迫综合征的表型
Br J Anaesth. 2021 Mar;126(3):e130-e132. doi: 10.1016/j.bja.2020.12.023. Epub 2020 Dec 26.
5
Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.比伐卢定在 COVID-19 体外膜肺氧合期间用于维持静脉-静脉体外膜氧合抗凝。
J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1149-1153. doi: 10.1053/j.jvca.2020.06.059. Epub 2020 Jun 25.
6
Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: How Do We Expand Capacity in the COVID-19 Era?急性呼吸窘迫综合征中的体外膜肺氧合：在新冠疫情时代我们如何扩大治疗能力？
Heart Lung Circ. 2021 May;30(5):623-625. doi: 10.1016/j.hlc.2021.03.001. Epub 2021 Mar 3.
7
Clinical data of early COVID-19 cases receiving extracorporeal membrane oxygenation in Wuhan, China.中国武汉 COVID-19 早期接受体外膜肺氧合治疗的病例的临床数据。
J Clin Anesth. 2021 Feb;68:110044. doi: 10.1016/j.jclinane.2020.110044. Epub 2020 Sep 14.
8
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.成功应用清醒体外膜肺氧合治疗重症新型冠状病毒肺炎患者：一例报告
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
9
Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic.COVID-19 大流行期间的静脉-静脉体外膜肺氧合分配。
J Crit Care. 2021 Feb;61:221-226. doi: 10.1016/j.jcrc.2020.11.004. Epub 2020 Nov 13.
10
Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.体外膜肺氧合治疗武汉危重新冠病毒病 2019 患者：一项回顾性多中心队列研究。
Curr Med Sci. 2021 Feb;41(1):1-13. doi: 10.1007/s11596-021-2311-8. Epub 2021 Feb 13.
引用本文的文献
1
Control of Cardiac Output with Ivabradine or Beta-Blockers for Refractory Hypoxemia under Veno-Venous ECMO for Severe ARDS.在严重急性呼吸窘迫综合征的静脉-静脉体外膜肺氧合支持下，使用伊伐布雷定或β受体阻滞剂控制难治性低氧血症时的心输出量。
Cardiovasc Drugs Ther. 2024 Dec 30. doi: 10.1007/s10557-024-07650-5.
2
COVID-19: Some unresolved issues.新型冠状病毒肺炎（COVID-19）：一些未解决的问题。
Rev Esp Quimioter. 2022 Oct;35(5):421-434. doi: 10.37201/req/028.2022. Epub 2022 Apr 21.
3
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists.COVID-19 患者体外膜肺氧合（ECMO）：放射科医生袖珍指南。
Radiol Med. 2022 Apr;127(4):369-382. doi: 10.1007/s11547-022-01473-w. Epub 2022 Mar 13.
4
Case Report: Respiratory Management With a 47-Day ECMO Support for a Critical Patient With COVID-19.病例报告：一名新冠肺炎重症患者接受47天体外膜肺氧合支持的呼吸管理
Front Med (Lausanne). 2021 Dec 24;8:714387. doi: 10.3389/fmed.2021.714387. eCollection 2021.
5
Finding of the factors affecting the severity of COVID-19 based on mathematical models.基于数学模型的 COVID-19 严重程度影响因素的发现。
Sci Rep. 2021 Dec 20;11(1):24224. doi: 10.1038/s41598-021-03632-x.
6
Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2).用于2019冠状病毒病所致急性呼吸窘迫综合征的体外膜肺氧合：第一波与第二波疫情期间的比较（第2阶段）
J Clin Med. 2021 Oct 21;10(21):4839. doi: 10.3390/jcm10214839.
7
Risk Stratification for ECMO Requirement in COVID-19 ICU Patients Using Quantitative Imaging Features in CT Scans on Admission.利用入院时CT扫描的定量影像特征对COVID-19重症监护病房患者进行体外膜肺氧合需求的风险分层
Diagnostics (Basel). 2021 Jun 3;11(6):1029. doi: 10.3390/diagnostics11061029.
8
Coinfections in Patients Hospitalized with COVID-19: A Descriptive Study from the United Arab Emirates.新冠肺炎住院患者的合并感染：来自阿拉伯联合酋长国的描述性研究。
Infect Drug Resist. 2021 Jun 21;14:2289-2296. doi: 10.2147/IDR.S314029. eCollection 2021.
9
Implementation of new ECMO centers during the COVID-19 pandemic: experience and results from the Middle East and India.COVID-19 大流行期间新的体外膜肺氧合（ECMO）中心的实施：来自中东和印度的经验和结果。
Intensive Care Med. 2021 Aug;47(8):887-895. doi: 10.1007/s00134-021-06451-w. Epub 2021 Jun 22.
10
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.体外膜肺氧合治疗 COVID-19 的系统评价和荟萃分析。
Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1.
本文引用的文献
1
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
2
How severe COVID-19 infection is changing ARDS management.新型冠状病毒肺炎（COVID-19）感染的严重程度如何改变急性呼吸窘迫综合征（ARDS）的管理。
Intensive Care Med. 2020 Dec;46(12):2184-2186. doi: 10.1007/s00134-020-06245-6. Epub 2020 Sep 18.
3
Prone Positioning during Venovenous Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Multicenter Cohort Study and Propensity-matched Analysis.俯卧位通气在急性呼吸窘迫综合征行体外膜肺氧合治疗中的应用。一项多中心队列研究和倾向性匹配分析。
Ann Am Thorac Soc. 2021 Mar;18(3):495-501. doi: 10.1513/AnnalsATS.202006-625OC.
4
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.体外膜肺氧合治疗 COVID-19 相关严重急性呼吸窘迫综合征的回顾性队列研究。
Lancet Respir Med. 2020 Nov;8(11):1121-1131. doi: 10.1016/S2213-2600(20)30328-3. Epub 2020 Aug 13.
5
Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.体外膜肺氧合治疗 COVID-19 合并严重呼吸衰竭患者。
JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.
6
Provision of ECPR during COVID-19: evidence, equity, and ethical dilemmas.COVID-19 期间的体外心肺复苏（ECPR）提供：证据、公平性和伦理困境。
Crit Care. 2020 Jul 27;24(1):462. doi: 10.1186/s13054-020-03172-2.
7
Integrating the evidence: confronting the COVID-19 elephant.整合证据：直面新冠疫情这头“大象”。
Intensive Care Med. 2020 Oct;46(10):1904-1907. doi: 10.1007/s00134-020-06195-z. Epub 2020 Jul 25.
8
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic.儿童多系统炎症综合征伴发急性心力衰竭：全球 SARS-CoV-2 大流行背景下的临床观察
Circulation. 2020 Aug 4;142(5):429-436. doi: 10.1161/CIRCULATIONAHA.120.048360. Epub 2020 May 17.
9
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
10
Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports.2019冠状病毒病（COVID-19）所致急性呼吸窘迫综合征（ARDS）患者接受体外膜肺氧合治疗的生存率较低：早期报告的汇总分析
J Crit Care. 2020 Aug;58:27-28. doi: 10.1016/j.jcrc.2020.03.011. Epub 2020 Apr 1.
Zotero 插件